Odin Biotech Partners
2014
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$2.2M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of drugs for diseases of the retina. The company develops novel therapeutics for debilitating ophthalmic diseases which can be used for the treatment of wet age-related macular degeneration.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 4441 Buena Vista Street
- Dallas, TX 75205
- United States
+1 (469) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Odin Biotech Partners’s full profile, request a free trial.
Odin Biotech Partners Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 28-Aug-2014 | $2.2M | 00.00 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Odin Biotech Partners Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Claria Bioscience | Other | Minority | 000 0000 | 000000 0 | ||
| 2M Companies | Family Office | Minority | 000 0000 | 000000 0 |
Odin Biotech Partners Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Karl Csaky Ph.D | Founder, Chief Medical Officer, Chief Executive Officer & Board Member |
Odin Biotech Partners Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Karl Csaky Ph.D | Odin Biotech Partners | Founder, Chief Medical Officer, Chief Executive Officer & Board Member | 000 0000 | |
| Melissa Krauth | 2M Companies | Interim Chief Executive Officer & Board Member | 000 0000 |